Prescription Pain Medications Market, Global Outlook and Forecast 2024-2031

Report ID: 1135277 | Published Date: Jan 2025 | No. of Page: 77 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story

This report contains market size and forecasts of Prescription Pain Medications in global, including the following market information:
Global Prescription Pain Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prescription Pain Medications Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prescription Pain Medications companies in 2021 (%)
The global Prescription Pain Medications market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription NSAIDs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prescription Pain Medications include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Pain Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Pain Medications Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Pain Medications Market Segment Percentages, by Type, 2021 (%)
Prescription NSAIDs
Opioids
Anti-epileptic Medicines
Antidepressants
Others
Global Prescription Pain Medications Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Pain Medications Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Drugstores
Others
Global Prescription Pain Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Pain Medications Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Pain Medications revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prescription Pain Medications revenues share in global market, 2021 (%)
Key companies Prescription Pain Medications sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prescription Pain Medications sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Teva
J&J
Allergan

Frequently Asked Questions
Prescription Pain Medications Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prescription Pain Medications Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prescription Pain Medications Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports